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A 47-year-old female was admitted for “abdominal distension with nausea and vomiting 
for eight days” and had no previous medical history, including hypertension or syncope. 
Abdominal computed tomography (CT) showed a 3.1 cm × 3.7 cm × 4.5 cm round mass 
shadow at the border between the descending and horizontal segments of the duodenum and 
behind the head of the pancreas on January 30, 2019 (Fig. 1). The round mass was 
misdiagnosed as “stromal tumour” and underwent laparoscopic resection on February 19, 
2019. Blood pressure and heart rate increased sharply until ventricular fibrillation occurred 
when the tumour was touched with the instrument after general anaesthesia 
(Propofol/Remifentanil/Sevoflurane). The operation had to be stopped and cardiopulmonary 
resuscitation was performed. After cardiac recovery, left ventricular ejection fraction (LVEF) 
was 25% and fraction shortening (FS) was 12% by transthoracic echocardiography, and 
plasma catecholamines metabolites were significantly increased (m-norepinephrine 427.6 
ng/L, norepinephrine 360.2 ng/L, vanilla-bitter almond acid (VMA) 213.2 ng/mL, 
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catecholamine 180.1 ng/mL). The patient was diagnosed with catecholamine cardiomyopathy 
and cardiogenic shock, and then sent to surgical ICU (SICU) for PICCO monitoring and 
anti-shock treatment.  
After the patient was sent to SICU, blood pressure was maintained with cardiac drugs 
(dopamine/dobutamine) and norepinephrine, but ECMO treatment was rejected by the 
patient's families. Variables (PICCO parameters/EF values/cTnT) of the first six days after 
surgery are shown in Table 1. During cardiogenic shock our goal is to ensure that the level of 
lactic acid is < 2 mmol/L, while mean arterial pressure and cardiac preload (GEDI) are as low 
as possible. Sustained ventricular tachycardia occurred on the first day and returned to sinus 
rhythm on the third day (ECG shown in Fig. 2). Lidocaine was not effective in correcting 
arrhythmia. On the 4–5th day, the patient's LVEF began to improve significantly and 
mechanical ventilation was stopped. On the sixth day after surgery, LVEF and plasma 
catecholamine metabolite levels returned to normal, and cardiotonic agents were discontinued. 
The patient was discharged without any complications but still had symptoms of abdominal 
distension and progressive aggravation.  
She was revisited on July 22, 2019. LVEF was 64% and plasma catecholamine 
metabolites were increased (m-norepinephrine 1119.6 ng/L, norepinephrine 1949.5 ng/L, 
VMA 586.5 ng/mL, catecholamine 369.3 ng/mL). Abdominal CT showed that the mass was 
slightly larger than before, with a size of about 4 cm × 3.5 cm × 4.8 cm. Iodine 131-labeled 
metaiodobenzylguanidine scintigraphy showed abnormal radioactivity accumulation in the 
right adrenal region at 24 h, 48 h, and 72 h (Fig. 3, imaging at 48 h). The patient underwent 
successful tumour resection on September 3, 2019 after two weeks of treatment with 
phenbenzamine (20 mg tid) and was confirmed as pheochromocytoma by pathological 
examination (Fig. 4). 
 
Pheochromocytoma is a rare neuroendocrine tumour, which can be acute and even 
life-threatening, and which is associated with the sudden release of large amounts of 
catecholamines [1]. The most common symptoms of pheochromocytoma are palpitations, 
hyperhidrosis, and headache [2], and a small number of patients will present with acute 
catecholamine cardiomyopathy [3], and life-threatening acute myocardial injury and 
3 
 
dysfunction. Cardiogenic shock, circulatory failure, and multisystem damage are the main 
manifestations of catecholamine cardiomyopathy and are very likely to cause patient death. 
Therefore, early identification of pheochromocytoma, enhanced preoperative management, as 
well as prevention of acute catecholamine cardiomyopathy occurrence are essential [4].  
Our patient was misdiagnosed as intestinal stromal tumour before the first operation and 
thus did not receive effective preoperative preparation, resulting in intraoperative acute 
catecholamine cardiomyopathy and sudden cardiac arrest. Myocardial toxicity from high 
circulating catecholamine production by pheochromocytoma causes cardiomyopathy in a 
minority of patients, manifesting as cardiac hypertrophy or dilated cardiomyopathy, which can 
be present at any age, including childhood. Echocardiography can visualise a decreased 
ejection fraction (EF) and wall motion abnormalities [5]. Our case did not present with 
cardiomyopathy, but hyperactive heart disease during surgery became the main manifestation, 
with an initial score of only 15%, and recurrent ventricular fibrillation, a hyperactive 
catecholamine cardiomyopathy that is rarely reported.  
As can be observed in our case, acute catecholamine cardiomyopathy is reversible, and 
the left ventricular fraction recovers to 45% after 3~4 days. The focus of treatment is 
tantamount to correct tissue hypoperfusion at the stage of cardiogenic shock, while avoiding 
excessive fluid and increasing the burden on the heart. Accurate haemodynamic monitoring 
(such as PICCO/cardiac ultrasound) and ECMO can help the rehabilitation of patients. 
Although there are also examples of successful surgery without preoperative drug preparation, 
we still recommend preoperative medication due to the potential possibility of acute 
catecholamine cardiomyopathy and sudden cardiac arrest. 
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Figure 1. Abdominal computed tomography image 
 
Figure 2. Electrocardiogram of the first 4 days after surgery. Days 1–2: ventricular 
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tachycardia; Day 3: nodal tachycardia, paroxysmal ventricular tachycardia; Day 3: nodal 
tachycardia, first-degree atrioventricular block. 
 
 
Figure 3. Iodine131-labeled metaiodobenzylguanidine scintigraphy. Abnormal radioactivity 
accumulation in the right adrenal region at 48 h 
 
 
Figure 4. Pathological examination 
 
 
Table 1. Variables of the first 6 days after surgery 
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Variables Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
CI [L/min/m2] 1.98 2.05 2.09 2.82 3.05 - 
GEDI [mL/m2] 706 604 673 710 642 - 
SVRI [dyns/cm-5m2] 3210 2447 2102 1921 1756 - 
ELWI [mL/kg] 10.1 9.9 8.9 9.7 8.0 - 
EF (%) 23 30 30 34 45 50 
cTnT [μg/L] 4.99 3.14 2.54 3.04 1.55 0.865 
NT-proBNP [ng/L] 7823 18300 26456 19359 12423 609 
CI — cardiac index; GEDI — global end-diastolic volume index; SVRI — systemic vascular 
resistance index; ELWI — extra vascular lung water index; EF — ejection fraction 
 
 
